Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Shu-Tao Tan"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling
Shu-Tao Tan, Sheng-Ye Liu, Bin Wu
Cancer Res Treat. 2016;48(4):1302-1312.   Published online March 11, 2016
DOI: https://doi.org/10.4143/crt.2015.381
AbstractAbstract PDFPubReaderePub
Purpose
TRIM29 overexpression has been reported in several human malignancies and showed correlation with cancer cell malignancy. The aim of the current study is to examine its clinical significance and biological roles in human bladder cancer tissues and cell lines. Materials and Methods A total of 102 cases of bladder cancer tissues were examined for TRIM29 expression by immunohistochemistry. siRNA and plasmid transfection were performed in 5637 and BIU- 87 cell lines. Cell Counting Kit-8, flow cytometry, western blot, and real-time polymerase chain reaction were performed to examine its biological roles and mechanism in bladder cancer cells.
Results
We found that TRIM29 overexpression showed correlation with invading depth (p=0.0087). Knockdown of TRIM29 expression in bladder cancer cell line 5637 inhibited cell growth rate and cell cycle transition while its overexpression in BIU-87 cells accelerated cell proliferation and cell cycle progression. TRIM29 overexpression also inhibited cell apoptosis induced by cisplatin. In addition, we demonstrated that TRIM29 depletion decreased while its overexpression led to upregulated expression of cyclin D1, cyclin E, and Bcl-2. We also showed that TRIM29 knockdown inhibited protein kinase C (PKC) and nuclear factor κB (NF-κB) signaling while its overexpression stimulated the PKC and NF-κB pathways. BAY 11-7082 (NF-κB inhibitor) partly attenuated the effect of TRIM29 on expression of cyclin and Bcl-2. Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-κB. Conclusion The current study demonstrated that TRIM29 upregulates cyclin and Bcl family proteins level to facilitate malignant cell growth and inhibit drug-induced apoptosis in bladder cancer, possibly through PKC–NF-κB signaling pathways.

Citations

Citations to this article as recorded by  
  • TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
    Qitong Wu, Deeptashree Nandi, Dipali Sharma
    Cancer and Metastasis Reviews.2025;[Epub]     CrossRef
  • Role of TRIM29 in disease: What is and is not known
    Kunying Lv, Qilong Li, Ning Jiang, Qijun Chen
    International Immunopharmacology.2025; 147: 113983.     CrossRef
  • Lactate dehydrogenase A promotes nasopharyngeal carcinoma progression through the TAK1/NF-κB Axis
    Yingzi Li, Lanfang Chen, Qiaochong Zheng, Guanxin Liu, Mengjiao Wang, Shupei Wei, Tao Chen
    Molecular Biology Reports.2024;[Epub]     CrossRef
  • Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50
    Min Wu, Meng-Meng Jin, Xiao-Hui Cao, Lei Zhao, Yong-Huai Li
    Current Cancer Drug Targets.2024; 24(4): 445.     CrossRef
  • 20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65
    Qiang Ma, Fei Wu, Xiaohui Liu, Cuifang Zhao, Yang Sun, Yuanyuan Li, Wei Zhang, Hongge Ju, Yukun Wang
    Translational Oncology.2024; 45: 101958.     CrossRef
  • The Role and Mechanism of TRIM Proteins in Gastric Cancer
    Wangxi Wu, Jinyu Yang, Tian Yu, Zhuoling Zou, Xuan Huang
    Cells.2024; 13(24): 2107.     CrossRef
  • Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
    Junjie Gu, Jingyi Chen, Shuaixi Xiang, Xikun Zhou, Jing Li
    Journal of Advanced Research.2023; 54: 147.     CrossRef
  • TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway
    Xiaohong Xu, Zihan Qin, Ce Zhang, Xia Mi, Chi Zhang, Feihong Zhou, Junsheng Wang, Liexiang Zhang, Fei Hua
    Cell Biology International.2023; 47(6): 1126.     CrossRef
  • Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions
    Rishi Kant Singh, Sanjay Kumar, Sandeep Kumar, Alok Shukla, Naveen Kumar, Anand Kumar Patel, Lokesh Kumar Yadav, Kaushalendra, Meera Antiwal, Arbind Acharya
    Life Sciences.2023; 330: 121999.     CrossRef
  • TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation
    Yuanjian Chen, Jun Ma, Mingming Zhang
    Experimental Biology and Medicine.2023; 248(18): 1527.     CrossRef
  • TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis
    Mohammadreza Roshanazadeh, mojtaba rashidi, Arash sanaei, Hossein azizi dariuni, amirnader emami razavi, Maryam Adelipour
    Journal of Breast Disease.2023; 16(4): 4.     CrossRef
  • TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer
    Huai-Yu Qiao, Qi Zhang, Jia-Mei Wang, Jing-Yi Jiang, Ling-Yue Huyan, Jing Yan, Chao Li, Hua-Qin Wang
    Cancer Letters.2022; 529: 85.     CrossRef
  • NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway
    Feng Tang, Hua Yu, Xia Wang, Jiageng Shi, Zhizhuang Chen, Hao Wang, Ziyu Wan, Qiqi Fu, Xuan Hu, Yisha Zuhaer, Tao Liu, Zhonghua Yang, Jianping Peng
    Biochemical and Biophysical Research Communications.2022; 622: 101.     CrossRef
  • Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma
    Tanmin Lu, Yu Wu
    Hormone and Metabolic Research.2022; 54(12): 859.     CrossRef
  • TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients
    Mohammad Reza Roshanazadeh, Maryam Adelipour, Arash Sanaei, Hadi Chenane, Mojtaba Rashidi
    BMC Research Notes.2022;[Epub]     CrossRef
  • Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
    Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata, Jeong-Hun Kang
    Cancers.2022; 14(21): 5425.     CrossRef
  • Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism
    Jing Han, Zitong Zhao, Nan Zhang, Yang Yang, Liying Ma, Li Feng, Xue Zhang, Jing Zuo, Zhisong Fan, Yudong Wang, Yongmei Song, Guiying Wang
    Aging.2021; 13(4): 5034.     CrossRef
  • E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1
    Xueqiang Deng, Xiaowei Fu, Hong Teng, Lu Fang, Bo Liang, Rengui Zeng, Lian Chen, Yeqing Zou
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
    Yang Wang, Huaicheng Tan, Ting Yu, Xiaoxuan Chen, Fangqi Jing, Huashan Shi
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • TRIM29 in Cutaneous Squamous Cell Carcinoma
    Che-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
    Julie Girouard, Denise Belgorosky, Jovane Hamelin-Morrissette, Valerie Boulanger, Ernesto D'Orio, Djamel Ramla, Robert Perron, Lucie Charpentier, Céline Van Themsche, Ana Maria Eiján, Gervais Bérubé, Carlos Reyes-Moreno
    Biochemical Pharmacology.2020; 176: 113778.     CrossRef
  • Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation
    Jia Sun, Jing Yan, Huai-Yu Qiao, Fu-Ying Zhao, Chao Li, Jing-Yi Jiang, Bao-Qin Liu, Xiao-Na Meng, Hua-Qin Wang
    Oncogene.2020; 39(3): 546.     CrossRef
  • The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
    Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin


    Zhibing Ou, Hua Zhong, Liang Zhang, Minghua Deng, Wenfeng Zhang, Jingyuan Wang, Huaguo Feng, Jianping Gong, Chunmu Miao, Zhujun Yi
    International Journal of Nanomedicine.2020; Volume 15: 4125.     CrossRef
  • TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis
    Fengyu Wang, Haili Wang, Lei Sun, Chengling Niu, Jie Xu
    American Journal of Physiology-Cell Physiology.2020; 319(2): C392.     CrossRef
  • TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin
    Weifeng Xu, Beibei Chen, Dianshan Ke, Xiaobing Chen
    Aging.2020; 12(13): 13488.     CrossRef
  • Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p
    Shunxiang Luo, Ming Shen, Hui Chen, Weiwei Li, Cong Chen
    Molecular Medicine Reports.2020;[Epub]     CrossRef
  • Robust Sample-Specific Stability Selection with Effective Error Control
    Heewon Park, Makoto Yamada, Seiya Imoto, Satoru Miyano
    Journal of Computational Biology.2019; 26(3): 202.     CrossRef
  • Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway
    Hao Shen, Jiawei Zhang, Yaodong Zhang, Qinchao Feng, Hongwei Wang, Gaochao Li, Wangjie Jiang, Xiangcheng Li
    Gene.2019; 698: 50.     CrossRef
  • MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29
    Huimin Du, Qing Xu, Sheng Xiao, Zhenru Wu, Jianping Gong, Changan Liu, Guosheng Ren, Hao Wu
    Life Sciences.2019; 224: 1.     CrossRef
  • ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/β-catenin signaling
    Yidong Cao, Luoning Shi, Maode Wang, Juanru Hou, Yanqiang Wei, Changwang Du
    Chemico-Biological Interactions.2019; 305: 148.     CrossRef
  • MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling
    Haili Tian, Xiaoqiang Wang, Jianfeng Lu, Weiping Tian, Peijie Chen
    Chemico-Biological Interactions.2019; 308: 244.     CrossRef
  • Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling
    Gang Li, Meng Wang, Liangliang Ren, Hanzong Li, Qinghua Liu, Ying Ouyang, Lixin He, Fengyan Li
    Biomedicine & Pharmacotherapy.2019; 117: 109112.     CrossRef
  • ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK‐3β/Wnt/β‐catenin signalling
    Weizhi Li, Hui Xue, Yingchao Li, Peijie Li, Fuquan Ma, Mengying Liu, Shuzhen Kong
    Clinical and Experimental Pharmacology and Physiology.2019; 46(9): 845.     CrossRef
  • MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression
    Feng Li, Jing Liang, Lu Bai
    Biomedicine & Pharmacotherapy.2018; 103: 782.     CrossRef
  • iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma
    Kun Wang, Zhen Chen, Lu Long, Ya Tao, Qiong Wu, Manlin Xiang, Yunlai Liang, Xulin Xie, Yuan Jiang, Zhiqiang Xiao, Yahui Yan, Shiyang Qiu, Bin Yi
    Cancer Biology & Therapy.2018; 19(9): 809.     CrossRef
  • TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis
    Chao Liang, Huiyu Dong, Chenkui Miao, Jundong Zhu, Jie Wang, Pu Li, Jie Li, Zengjun Wang
    Oncotarget.2018; 9(15): 12323.     CrossRef
  • Overexpression of sigma‑1 receptor in MCF‑7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway
    Yuqi Wu, Xueyan Bai, Xiaoyang Li, Chang Zhu, Zachary Wu
    Oncology Letters.2018;[Epub]     CrossRef
  • TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
    Ye Sun, Bing Ji, Yifei Feng, Yue Zhang, Dongjian Ji, Chunyan Zhu, Sen Wang, Chuan Zhang, Dongsheng Zhang, Yueming Sun
    Oncology Reports.2017; 38(1): 43.     CrossRef
  • TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway
    Jinkai Xu, Zongyu Li, Qinghua Su, Jun Zhao, Jiancang Ma
    Oncology Reports.2017; 37(3): 1555.     CrossRef
  • Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/JAK2/Stat3 signaling pathway
    Yongliang Ni, Shaohua Zhao, Xiaoxuan Yin, Haixin Wang, Qianqian Guang, Guangxia Hu, Yi Yang, Shoubin Jiao, Benkang Shi
    Scientific Reports.2017;[Epub]     CrossRef
  • High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial-mesenchymal transition in osteosarcoma
    Si-Xiang Zeng, Qing-Chun Cai, Chi-Hua Guo, Li-Qiang Zhi, Xing Dai, Dang-Feng Zhang, Wei Ma
    Oncology Reports.2017; 38(3): 1645.     CrossRef
  • MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C
    Xuefeng He, Jigen Ping, Duangai Wen
    Experimental and Therapeutic Medicine.2017; 14(4): 3253.     CrossRef
  • 12,363 View
  • 202 Download
  • 46 Web of Science
  • 43 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP